Halime Kalkavan

1.7k total citations · 2 hit papers
16 papers, 1.1k citations indexed

About

Halime Kalkavan is a scholar working on Molecular Biology, Oncology and Epidemiology. According to data from OpenAlex, Halime Kalkavan has authored 16 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 6 papers in Oncology and 6 papers in Epidemiology. Recurrent topics in Halime Kalkavan's work include Autophagy in Disease and Therapy (5 papers), Cell death mechanisms and regulation (5 papers) and Phagocytosis and Immune Regulation (3 papers). Halime Kalkavan is often cited by papers focused on Autophagy in Disease and Therapy (5 papers), Cell death mechanisms and regulation (5 papers) and Phagocytosis and Immune Regulation (3 papers). Halime Kalkavan collaborates with scholars based in United States, Germany and United Kingdom. Halime Kalkavan's co-authors include Douglas R. Green, Jeremy Chase Crawford, Giovanni Quarato, Jinan Chen, Patrick Fitzgerald, Colin R. Goding, Stephen W. G. Tait, Michael D. L. Johnson, Robert Carter and David Finkelstein and has published in prestigious journals such as Cell, Proceedings of the National Academy of Sciences and Genes & Development.

In The Last Decade

Halime Kalkavan

14 papers receiving 1.1k citations

Hit Papers

MOMP, cell suicide as a BCL-2 family business 2017 2026 2020 2023 2017 2022 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Halime Kalkavan United States 10 719 303 256 188 173 16 1.1k
Zhenyu Cai China 16 927 1.3× 396 1.3× 211 0.8× 154 0.8× 169 1.0× 28 1.2k
Jinho Seo South Korea 16 715 1.0× 183 0.6× 155 0.6× 199 1.1× 148 0.9× 30 975
Hongxiu Yu China 20 938 1.3× 262 0.9× 265 1.0× 186 1.0× 268 1.5× 60 1.6k
Denis E. Reyna United States 13 1.3k 1.8× 197 0.7× 201 0.8× 227 1.2× 159 0.9× 15 1.6k
Jun Jin China 22 631 0.9× 311 1.0× 149 0.6× 130 0.7× 288 1.7× 59 1.2k
Yanling Zhao China 22 1.0k 1.4× 240 0.8× 176 0.7× 385 2.0× 348 2.0× 48 1.5k
Marta Martínez Spain 16 717 1.0× 177 0.6× 128 0.5× 262 1.4× 299 1.7× 28 1.2k
Aintzane Asumendi Spain 22 723 1.0× 346 1.1× 112 0.4× 259 1.4× 144 0.8× 47 1.2k
Jayshree L. Hirpara Singapore 16 746 1.0× 123 0.4× 207 0.8× 204 1.1× 257 1.5× 28 1.1k
Jianchun Wu China 18 753 1.0× 174 0.6× 195 0.8× 256 1.4× 206 1.2× 46 1.1k

Countries citing papers authored by Halime Kalkavan

Since Specialization
Citations

This map shows the geographic impact of Halime Kalkavan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Halime Kalkavan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Halime Kalkavan more than expected).

Fields of papers citing papers by Halime Kalkavan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Halime Kalkavan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Halime Kalkavan. The network helps show where Halime Kalkavan may publish in the future.

Co-authorship network of co-authors of Halime Kalkavan

This figure shows the co-authorship network connecting the top 25 collaborators of Halime Kalkavan. A scholar is included among the top collaborators of Halime Kalkavan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Halime Kalkavan. Halime Kalkavan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
2.
Metzenmacher, Martin, Fabian Doerr, Servet Bölükbas, et al.. (2025). BCL-B Promotes Lung Cancer Invasiveness by Direct Inhibition of BOK. Cells. 14(4). 246–246. 1 indexed citations
3.
Lever, M. J., Simon Bogner, Fabian Mairinger, et al.. (2024). Prognostic value of clinical and radiomic parameters in patients with liver metastases from uveal melanoma. Pigment Cell & Melanoma Research. 37(6). 831–838.
4.
Kalkavan, Halime, Sebastian Rühl, Jeremy J.P. Shaw, & Douglas R. Green. (2023). Non-lethal outcomes of engaging regulated cell death pathways in cancer. Nature Cancer. 4(6). 795–806. 27 indexed citations
5.
Khan, Sameer Ullah, Kaneez Fatima, Fayaz Malik, Halime Kalkavan, & Abubakar Wani. (2023). Cancer metastasis: Molecular mechanisms and clinical perspectives. Pharmacology & Therapeutics. 250. 108522–108522. 53 indexed citations
6.
Rodríguez, Diego A., Giovanni Quarato, Swantje Liedmann, et al.. (2022). Caspase-8 and FADD prevent spontaneous ZBP1 expression and necroptosis. Proceedings of the National Academy of Sciences. 119(41). e2207240119–e2207240119. 45 indexed citations
7.
Kalkavan, Halime, Jinan Chen, Jeremy Chase Crawford, et al.. (2022). Sublethal cytochrome c release generates drug-tolerant persister cells. Cell. 185(18). 3356–3374.e22. 138 indexed citations breakdown →
8.
Herbert, Katharine, Jean‐Philippe Lambert, Pakavarin Louphrasitthiphol, et al.. (2019). BRN2 suppresses apoptosis, reprograms DNA damage repair, and is associated with a high somatic mutation burden in melanoma. Genes & Development. 33(5-6). 310–332. 25 indexed citations
9.
Cunha, Larissa D., Mao Yang, Robert Carter, et al.. (2018). LC3-Associated Phagocytosis in Myeloid Cells Promotes Tumor Immune Tolerance. Cell. 175(2). 429–441.e16. 242 indexed citations
10.
Follis, Ariele Viacava, Fabien Llambi, Halime Kalkavan, et al.. (2018). Regulation of apoptosis by an intrinsically disordered region of Bcl-xL. Nature Chemical Biology. 14(5). 458–465. 36 indexed citations
11.
Kalkavan, Halime & Douglas R. Green. (2017). MOMP, cell suicide as a BCL-2 family business. Cell Death and Differentiation. 25(1). 46–55. 511 indexed citations breakdown →
12.
Gassa, Asmae, Halime Kalkavan, Vikas Duhan, et al.. (2016). High Frequencies of Anti-Host Reactive CD8+ T Cells Ignore Non-Hematopoietic Antigen after Bone Marrow Transplantation in a Murine Model. Cellular Physiology and Biochemistry. 38(4). 1343–1353. 5 indexed citations
13.
Gassa, Asmae, Halime Kalkavan, Vikas Duhan, et al.. (2016). IL-10 Induces T Cell Exhaustion During Transplantation of Virus Infected Hearts. Cellular Physiology and Biochemistry. 38(3). 1171–1181. 9 indexed citations
14.
Herpen, C. van, Michael A. Postow, Matteo S. Carlino, et al.. (2015). 3300 A phase 1b/2 study of ribociclib (LEE011; CDK4/6 inhibitor) in combination with binimetinib (MEK162; MEK inhibitor) in patients with NRAS-mutant melanoma. European Journal of Cancer. 51. S663–S663. 18 indexed citations
15.
Breitenbuecher, Frank, Halime Kalkavan, Stefan Kasper, et al.. (2014). Functional expression cloning identifies COX-2 as a suppressor of antigen-specific cancer immunity. Cell Death and Disease. 5(12). e1568–e1568. 36 indexed citations
16.
Hoerning, André, Halime Kalkavan, Julia Menke, et al.. (2011). Quantitative real‐time ARMS‐qPCR for mitochondrial DNA enables accurate detection of microchimerism in renal transplant recipients. Pediatric Transplantation. 15(8). 809–818. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026